Skip to main content
Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
15.30
-0.30 (-1.92%)
At close: Apr 28, 2026, 4:00 PM EDT
15.40
+0.10 (0.65%)
Pre-market: Apr 29, 2026, 6:17 AM EDT

Fulgent Genetics Revenue

In the year 2025, Fulgent Genetics had annual revenue of $322.67M with 13.83% growth. Fulgent Genetics had revenue of $83.34M in the quarter ending December 31, 2025, with 9.34% growth.

Revenue (ttm)
$322.67M
Revenue Growth
+13.83%
P/S Ratio
1.37
Revenue / Employee
$245,377
Employees
1,315
Market Cap
441.32M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025322.67M39.20M13.83%
Dec 31, 2024283.47M-5.74M-1.99%
Dec 31, 2023289.21M-329.76M-53.27%
Dec 31, 2022618.97M-373.62M-37.64%
Dec 31, 2021992.58M570.87M135.37%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Myriad Genetics 824.50M
NeoGenomics 727.33M
OPKO Health 606.88M
GeneDx Holdings 427.54M
CareDx 379.81M
Castle Biosciences 344.23M
FONAR 106.03M
Prenetics Global 92.39M
Revenue Rankings

FLGT News

More News